Pfizer's Middle Way in VC

Pfizer's venture fund, Strategic Investment Group, focuses on commercial "enablers," technologies or services that can give Pfizer new ways of doing business, rather than at new molecules or drug delivery mechanisms. It leaves its drug-focused investments to its business development group.